COVID’s ‘Hidden Figure’ Addresses ‘Techanthropy’ and Small Business Challenges in New Product and National Column
BALTIMORE, MD / ACCESSWIRE / September 30, 2024 / Tiffany Tate, CEO of VAULT Technologies and a recognized leader in...
Healthcare
2024 Surescripts White Coat Award Recognizes 10 Healthcare Technology Leaders in Performance, Innovation and Accuracy
ARLINGTON, Va.--(BUSINESS WIRE)--#HealthIT--Surescripts®, the nation's leading health information network, awarded the 2024 Surescripts White Coat Award™ to 10 healthcare industry...
2024 Surescripts White Coat Award Recognizes 10 Healthcare Technology Leaders in Performance, Innovation and Accuracy
ARLINGTON, Va.--(BUSINESS WIRE)--#HealthIT--Surescripts®, the nation's leading health information network, awarded the 2024 Surescripts White Coat Award™ to 10 healthcare industry...
Study Indicates Significant Radiation Reduction for Breast Cancer Patients
Lumpectomy Patients Received VeraForm® Marker and APBI Therapy for Breast Cancer TreatmentSAN FRANCISCO, CA / ACCESSWIRE / September 30, 2024...
Axis Integrated Mental Health Recognized as Top Startup for Advancing Collaborative Mental Health Care
Top Startup Award Marks a Year of Milestones for Colorado's Leading Mental Health InnovatorWESTMINSTER, CO / ACCESSWIRE / September 30,...
Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-1403
CAMBRIDGE, MA / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first participant in the...
MediciNova to Support NIH-Funded Expanded Access Clinical Trial to Evaluate MN166 (ibudilast) in Amyotrophic Lateral Sclerosis (ALS)
Academic group to receive a total of $22 million for the trialLA JOLLA, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) --...
Clene Announces $7.3 Million Registered Direct Offering and Concurrent Private Placements Priced at Market Under Nasdaq Rules
SALT LAKE CITY, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its...
SS Innovations Welcomes Mr. Tim Adams, Leader in the Health Care Industry, to Board
Tim Adams to serve as Independent Board DirectorFORT LAUDERDALE, Fla., Sept. 30, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc....
ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
The new AirTouch™ N30i tube-up nasal mask for CPAP combines softness, breathability, and a high-performance, durable seal to provide exceptional...
ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
Dawn Dawn myAir MyAir LUXE LUXE ResMed makes it easier for people to manage their sleep health and stay on...
Wellinks Acquires Spire Health Creating Industry Leader in Predictive Patient Care for Cardiopulmonary Health
Current customers and patients will continue with existing programs while integrated and enhanced solutions are expected in coming monthsNEW HAVEN,...
AMN Healthcare to Hold Third Quarter 2024 Earnings Conference Call on Thursday, November 7, 2024
DALLAS, Sept. 30, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss...
Helius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP Study
-- Achieves primary endpoint showing a linear relationship between adherence to PoNS Therapy® in Phase 2 and improvement in DGI...
LUKE Awarded Top Workplaces 2024 Honor
ROCKLEDGE, Fla., Sept. 30, 2024 (GLOBE NEWSWIRE) -- LUKE Holdings, Inc. (“LUKE”), a trusted leader in healthcare staffing for the...
The Future is Now: Confronting Today’s Healthcare Challenges and Shaping Tomorrow’s Care at Empower
Inovalon’s Annual Data-Driven Summit Intersects Healthcare and Technology, Promising to Propel Meaningful Change Across the Care ContinuumBOWIE, Md., Sept. 30,...
Madrigal Pharmaceuticals Announces Publication of Positive Health-Related Quality of Life Results from the Phase 3 MAESTRO-NASH Trial of Rezdiffra™ (resmetirom)
Patients with MASH/NASH treated with Rezdiffra experienced clinically meaningful and statistically significant improvements in emotional well-being and health distressStudy results...
BridgeBio Completes Enrollment of FORTIFY, Phase 3 Registrational Study of BBP-418 in Limb-girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9)
- Study exceeded target enrollment, with an expected topline data readout from the interim analysis expected in 2025 - BridgeBio...
BrightSpring Health Services, Inc. Welcomes Dr. Steve Miller to Board of Directors
LOUISVILLE, Ky., Sept. 30, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “the Company”) (NASDAQ: BTSG), a leading provider...
Altimmune Completes Enrollment in Phase 2b IMPACT Trial of Pemvidutide in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
IMPACT trial is evaluating the safety and efficacy of pemvidutide in approximately 190 subjects with MASH; top-line efficacy data expected...